Tracked in our index — here's what we can read so far.
Longevity data is still building for this creative.
Running in a single market (QA) — a focused test, not a broad rollout yet.
- 1 GEO
- Redirect chain checked
- LP host: paid.outbrain.com
- Tracker: Outbrain
Reverse-engineered from the live ad — longevity, GEOs, and the affiliate funnel behind it. Verified by following the redirect chain on Jun 10. Free, no login.
Funnel, reverse-engineered
The campaign behind this creative
← the actual path the money takes.
Creative
Precision Medicine Online | Sponsored
Landing page
paid.outbrain.com
where it lands
Product / Offer: not detected
Tracker
Outbrain
detected
Affiliate network: not detected
How we know: the tracker and affiliate network come from the live redirect chain we followed and fingerprinted hop by hop. Greyed nodes weren’t detected.
Went quiet
last seen 9d ago · 1 market
No fresh sightings in over a week — momentum has dropped. Study it, don't chase it.
Gravity
18/100
push pressure now · 30d index
Strength
15/100
overall scale · 30d index
Run
—
last seen 9d ago
Markets
1
countries seen
Landing page
paid.outbrain.com
final host
Screenshot
—
not captured yet
Operator
—
unidentified
Network
Outbrain
traffic source
Roche, BioNTech Advance Personalized mRNA Vaccine Bladder Cancer Trial
Precision Medicine Online | Sponsored@precision
Days alive is a profitability proxy — advertisers don’t pay to run losers.
Seen in
Geo reach
Single-geo testa single marketPredominantly Tier 3, concentrated in MENA — QA.
What the data shows
Precision Medicine Online | Sponsored's Outbrain creative has been running for 0 days across 1 country and first seen on June 10, 2026. It has been observed in QA. The ad lands on paid.outbrain.com. On our 30-day observation series the creative has cooled noticeably in the last week. Precision Medicine Online | Sponsored is running 8 other creatives we have indexed, linked below for side-by-side comparison.
Creative headline: Roche, BioNTech Advance Personalized mRNA Vaccine Bladder Cancer Trial. Indexed on Outbrain by mediabuyer.
Landing-page intelligence
Landing page intelligence
Where this ad lands
The lander is the product — screenshot, redirect chain, offer, tech stack, and on-page text in one place.
Landing page not captured yet
Our crawler renders each advertiser’s funnel on a rolling schedule. Recently observed ads are queued first — check back to see the full-page screenshot.
Redirect chain
Chain not captured yet.
Final host: paid.outbrain.com. Hop-by-hop capture runs as a separate pipeline; ads observed in recent ingests get crawled first.
Tracking parameters
- p
- bWwRGEYzr_lOpbfqTnkBH1R8fHHJEBxwir87B_YSc5_hQsaJ6KoJBHyClwvz8OXInOHVxP9zwOit53kB4MS5ZoTwWzIf_6Fw9HIE3wnuSFEbmBdpnCR5BZJ3abgOVbUy8I7xm3hQSkb-L5nyWu7pKAss9m9NggfMMkdSbLo4S62Oet8xA9cUd0RDRswMwWJ4Wb8Ygrk_IdQychTIfH-FOwprC6baThGL1tp4aH2JYHs2TwqQs7W4sT46aT4-m3ExPUGPDjkDvmVx9q6_Rj2DaqAhZeNuRcl-EqwLDsbp8BeDsLSwSz3mIwnNMpDAXTd49_7h9i9n3nvoPq3Vz2vAlM5umAQPR-U_ttwnBkEVUat3ZCI2vWhATcKK0PNcbZ1XA3bRQxa5UAK2zPUEJJMOy4NorciMQVTZaM4KPhaxtKEckGmXa5epBPY7PGxdmAFNEpBbpC3bGzuoYZazgwuK1nCYJP4vaWheSm8xUYhuW1QqNSTiS1UP1cicCMd-9qxrK3B4f9d0klliUGoDxj0dgprExR1s_wzoEF-7ltyWoSINYFzWMZpDHTaMySylrp8jiGxUEGRpmC6P8oBXEHXGQrDR96yUTcJnPr86WO82RmOwpNKKrB4I1onAyl6fFjsEn6syrVinesia1eKtLfIM6bh_o4sRAZK1kMS11XqquJfceX9IbmvQsdY-uyJOGe1SPn4hIGDGJufYTT5jGB7agRyBK8whVwehbTjRCO1kJN6Wy0Rys8e3olbSM6-I8wRo42NXV8Hn6vAFF2_TSJA2SdTvrQShNJ5HsxS1UGj_UyduFZHNwEQ1mJ0XEPhU56lo1AhMFnCE60O0jkTKaSFMAEmsnaJ3-LQsAGInMT-3AnqJNVUe-I9aVEXFTQcVngBTnP4aBIL7EAkZ7M8De2VVNvtKCvr7CHvU5JSJWK5HW_XWvcMMxaKp06CYMVN6ebwSjm2EcVB47-scqzKBh2CipU8AH54o5CIoFQxzNYgbSc4yACHBirFgLUb5ZopASW6uEdDtGH8KCEanm9kf678KqSZq8DeEZzz_d0nCPSU77QF9yXcpTn7pzbcEqBdtAtflCME8A_Sz5h0T5fqVWKBujWRTky6B4iCBJ9AZAi8DkLPNmsXNtjEosWPu1EXu8sStOZ0JdcIoTwKXpLlpvj5vPy2Yrl4XTUk8mBC-b6wpZzooO3SyOtK7yyslBHt9GtZG2CpIYWwmaO6TrZ6VDSj57qBb8-U-ZXulGw-rVQCGJ3XJqpmCphC6MG87cR8T86SAFT_lLyMAcMDSXRNI8m2d54j0Hm_Kk1IZfsUx3wMbwyxKKxPfdsdQAgGjxj1WzjN_F_hBQVelXNmqptAURMzXO2E_8axcJ2QCkm-XibBO609C-2YBmIrck5zK13wYzBEpTAJn8eeTcgy_rSQl0f65wuTkL2sxoTKZMqqeWDI5PGcKS7bZ8N9Zky2wab_QuQnF1xe5jws5JXrUYBuXCHsYeevMkYl9qdZCfxVbUsEw9dJ2wZeLfcssL1fcK3y0oayOr2GPICzvrX4Mj9CgAzPrQQ9EGjYe1S74oO9Pm2spDCH1M_9oFDG3ci9kzg9VSFEoIkfbWw1kmO3pSymyrquqUW5Fb8UgYK_j67Tl7BoBMrtZSj0x2nNZSTVjTenlMJlYV-LWUPY2QpkxicUBfEwYUD2rJPNC6fLJheZILVX68Cb1fOUb7Dlwm85MKGyrj33kxzgvPlNl3r3TDlHuUKon8LKYAH88iP5bG5y9HyiboyxG1ZnN3j9WPbyutCBm-z68nT_Iy4KNnRa_Ym3EkX3WiJXi4iaykYOppnJcIw4GZp_AWYJ3h0NiSbj1NNI4sSQtf7Lw7Rv0hNzvw4eg1PSnCcBcPa0s8kBluGLeRqOh2LUKWkou9I4CJprVnqlJhyzOe4aznhUHk3_WqGTt1WUqd-xYKu6B__hX2ahNQhPJNthAcFbcJ4rvducDV8Zb_ZwV0WtJAuoPOzFGGXjpx7Ig2-5sJjS3Y9P3qHIcf9hrckhgCeTpy11emfujFwiM_SI164H9xqMtIL3x5gS-n63XeuMFSU1a7gggRPxwuDfz6t6lTkjM644U9Wo_BOtKIDIeWmZmT4f5GmCOr669GsCSBNYiqWT8FRj_CN_UiVSgFFajzKxyB_0fJ7KL1GnOmvDvY2ynjD4aO8NSaFti9J8qBQLUfTI_ej8elP_oVxldDwfZmcAqLiBCyKgONX586vTK-swUrUVSTVY7UbsinSU2H4m6IFymIJdFekuSvo6C-r9cZRU-Pr9avoRd8Qha8ydXF-qFmQpOWMi0Y-wFbrjmVZ-6PHES1_ZzZX0r9RY5B1MA-x0lySkHoD1oTG5YJDEDpOeJ16wsKrkQYsSwcY97xW3syYwEFc_s1zzb-7Oi5ksgIbwJZDMxFsLpZanzp4y0LYnPndViegyiEbvtVq6VHNMeCQrayVhC9WGA1DiWXWelPF38GkyoYy2Y_M0DuVFOtXOL7JAgpK-_8NUBC0dn4A3Evec_UCwMIGlQNfk8TsbJfZpd1oLjOTT_RHTFbpRpTXmsn_LY0TeKaXnWxAMBw26VuGZ3d6Gg_daphI-SslbuAAOvnHfI5pkdw00bD-vUtsS3tTyzgMxYgVHdL3q-PfK8eyta6oqo6KAgB7DLVwN6lu7ozkTiOp5mT4zzItiNjfPZ9DPdOP5mPzw4Q5lD22Au0p-KKCTk9PQFjBDB7aXU4Dyvfr-9ZrsEP6ugrRsG2t_OEuY9APdlJ9fWeJldJSkWVYfOx9iMQSivukQIKp7DGcrv5rWbC4iYR8Yv2IjAlVWNAyp3JTF6aHaLz_UF7qnec0TjpOZh9RPS1x3VCKeNFn3q9KJk-pBmDQ2cxVaNua_cQbD1OQTYWwIlNPOKEe9948niigwLhBujkZeRj7mNLUV6CHZJoNIAGj7Ob-e0IPfXbIQI4I9VhzLOagsgC5zC6Lm4yCwLVfegIwMNOL0IOdVuYFjREYtDxkNpSzvrH2AAbioGnCdsF3M7O4A4_PL4ODfrUtxZ-MRWpZlOqCTbI7DBmp9q_HKtOWF-mMEBbY9oPKt0qxBFAZ9NtFN6AUkQOnfd_K6Ec-1BI2QaZn2O1dJaPwLdhRdiOYrEb9hsNKhU9HC9DrfCwZ-MzmQBtHEdLQ6_eKr9xuA3hrf_2TaQ2jbtb0PXGQu8IqZGlmYA26epROFXyFwAs5oWXh5kSj5bVB8dZwk_9IH5d5xGzsT3KLIfrb-1QskymnbkOsiRXsX4KC0oCKgL03WI1f5Ynj2arhFF6GC0DapWlmo_s68xyVYHYqAbrFN_XMchOnXfbt_J9afJJP3YGdnGH_9V5ZccfFD0PEP9njneR7o84bY1cW8YffxB18GklIlV2s__EpM5GhxTC38FuB0Cp1g6I37lIoDAezSXAEmPgoe9h0n1JmEZDDY2caxQLuCh0nPUpKmFaZTHn0WKrTAI_AMSewJuJCJtVUGraQRE5Cycf_JqUwmURR1YPfhzdezIoCHXGebiyMZ4TGg2NxmHGxUwDKHkucAxwlC3KumGqVYAme3aJr1CLGeWioUNPKU_zcvrcedVA5Rlp2mbR1BTcYrUzqJDVXSp7S6O4D9RVpHUO1ScBrYMjMIp5kbKyUoo5TQ9hWIywtjKOiiSRgBL8KlbMULH5vQH_afCfRL-lzqqREhte003uDMCAtJTRKds_xTIhOopS6xpAfNyMH71NTdg7Fqjy3rUb-gjOeNtrlID8rGUVTtCDYcA5fxj2kbG5a3cycys4WTPP61depkGXajHmYc5fQjiziMhrf_9Ck0bUGgNeE1rWUJAfP_4aVNWI4bj0SNPi9Ma3NMRSINIPL_3z2HK7J2Ucsp8n02fNkBzeY-tXQl4RIu3O8PAc9YWyi8rSg647O__v48xqsrZ3jVGhFJNzdb4dB96Ts50_yBr7owzHwYm9PnPydWnhkmTDk-1F5RLs0524fDa3Rt4UZVARwKVmLys1p562Zr0KTAsQrb82lNq3KFee4TZznFCzvLzYg5oJNsrm2dzN9nWRfWwWGOXpTW1PS1wgEX5u0d73aIj9gaQZho6k-8Kk43FjCFzMt-4oq1scEfmUCb4tgtPMsGbbBefljVBfIaJh6TaCJ6a7E0Da4NfERHMy8ohopEQeCREJzV8WeEN_feGEZFhgJBJWkxr6w3Idu7S2VD2jfiaDbMSlaRlDC1Yliw_Q32hvaGn7V9Lj1UPFEcGXJJUAwjj0frarDZAH5HW_44I9tNR18EJTNgPXFWoPL9jd72VadcDkt3knQlrV8ljKoKIQjmt4PA_pz6ND1PUd3A4CxTD60yeq2sd8j-mSpZ9iGDJ0AlcEW1saFAyCXUOYtHJtg6bH4oWcSMPmZ2O7athjYOj_trDJ82742qaSiH7C5cEWHkprrkAi8w2OyOhB2kBGw2mJXwqKyzbMoBrYZTQiBAz2a1v6JGy9zYHN4C428SkjLZ4-Ymu9f7B4VOs6hjM2jz6zBIaqCF-FwLpEG32CgE
- c
- e987cf50
- v
- 3
- obOrigUrl
- true
+ 1 known tracker hidden (cloaker IDs scrubbed at ingest).
Tracking setup · Outbrain
Outbrain emits ob_click_id (your unique click), ob_source (publisher), ob_section (placement), and ob_position. Forward ob_click_id to your tracker as the postback key. ob_source and ob_section are the two highest-signal sub-IDs for blacklisting.
?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}Default Outbrain setup template: ?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}
Tech stack
No third-party monetization stack detected — this appears to be a direct landing page.
Landing page hubs
Landing page text
On-page text not extracted yet.
Observed daily (last 30 days)
May 21 → Jun 19·peaks Jun 10
30-day run pattern
FadingActivity has collapsed in the last week — the buyer is winding this creative down or rotating to a new variant.
- Coverage
- 3% of 30d
- Peak surge
- 1× vs median
- Last 7d
- 0
- WoW
- -100%
Peak day:
Window: May 21 → Jun 19
Sibling creatives from this campaign
Other creatives in Content Arb on Outbrain
The rest of the set they’re running — see what else this angle is paired with.
Clinicians Offering Early Access to Grail's MCED Test Await Full NHS Trial Readout After Endpoint Miss
Genetic Testing Becoming Routine Care at More Places, but Reimbursement Hurdles Linger, UPMC Survey Finds
IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment
Is It Time for Routine WGS in Cancer Patients? Dutch Researchers Say Yes
Roche, BioNTech Advance Personalized mRNA Vaccine Bladder Cancer Trial
Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 2026
LiquidCell Dx Developing Tumor Microenvironment Liquid Biopsy to Predict ICI Therapy Response
Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network
Tested headline variants8
Tested headline variants
Precision Medicine Online | Sponsored's own A/B test — which headline they kept
The advertiser’s own A/B result, handed over: ranked by days running, the survivor on top. Variants they stopped running are struck through — they tested and killed those angles.
- #1Clinicians Offering Early Access to Grail's MCED Test Await Full NHS Trial Readout After Endpoint MissWinning angle56d15 content tokens
- #2Mercy Bio Planning Limited Launch of Ovarian Cancer Screening Test in Q1 202648d11 content tokens
- #3Real-World Data Show Most Bladder Cancer Patients Getting Biomarker Testing in Community Network48d12 content tokens
- #4IHC Reference Standards Aim to Help Labs Measure Low HER2 Expression to Guide Enhertu Treatment33d13 content tokens
Winning angle: the headline they kept alive longest — it beat the other variants they tested. Model this one; treat the rest as discarded experiments.
More from Precision Medicine Online | Sponsored8
More from Precision Medicine Online | Sponsored
Most spy tools stop at the creative. This page connects it to the campaign behind it — the funnel, the longevity, the GEOs. Free.